These results confirmed previous findings [50–53], indicating lower naïve CD4+ and CD8+ T cell populations as well as higher effector memory CD8+ T cells in CLL vaccinees compared to healthy controls. The gene discussed is CD4; the disease is B-cell chronic lymphocytic leukemia.